OBJECTIVE: PCDH19-related epilepsy is characterized by a distinctive pattern of X-linked inheritance, where heterozygous females exhibit seizures and hemizygous males are asymptomatic. A cellular interference mechanism resulting from the presence of both wild-type and mutant PCDH19 neurons in heterozygous patients or mosaic carriers of PCDH19 variants has been hypothesized. We aim to investigate seizure susceptibility and progression in the Pchd19 mouse model. METHODS: We assessed seizure susceptibility and progression in the Pcdh19 mouse model using three acute seizure induction paradigms. We first induced focal, clonic seizures using the 6-Hz psychomotor test. Mice were stimulated with increasing current intensities and graded according to a modified Racine scale. We next induced generalized seizures using flurothyl or pentylenetetrazol (PTZ), both γ-aminobutyric acid type A receptor function inhibitors, and recorded latencies to myoclonic and generalized tonic-clonic seizures. RESULTS: Pcdh19 knockout and heterozygous females displayed increased seizure susceptibility across all current intensities in the 6-Hz psychomotor test, and increased severity overall. They also exhibited shorter latencies to generalized seizures following flurothyl, but not PTZ, seizure induction. Hemizygous males showed comparable seizure incidence and severity to their wild-type male littermates across all paradigms tested. SIGNIFICANCE: The heightened susceptibility observed in Pcdh19 knockout females suggests additional mechanisms other than cellular interference are at play in PCDH19-related epilepsy. Further experiments are needed to understand the variability in seizure susceptibility so that this model can be best utilized toward development of future therapeutic strategies for PCDH19-related epilepsy.
OBJECTIVE:PCDH19-related epilepsy is characterized by a distinctive pattern of X-linked inheritance, where heterozygous females exhibit seizures and hemizygous males are asymptomatic. A cellular interference mechanism resulting from the presence of both wild-type and mutant PCDH19 neurons in heterozygous patients or mosaic carriers of PCDH19 variants has been hypothesized. We aim to investigate seizure susceptibility and progression in the Pchd19 mouse model. METHODS: We assessed seizure susceptibility and progression in the Pcdh19mouse model using three acute seizure induction paradigms. We first induced focal, clonic seizures using the 6-Hz psychomotor test. Mice were stimulated with increasing current intensities and graded according to a modified Racine scale. We next induced generalized seizures using flurothyl or pentylenetetrazol (PTZ), both γ-aminobutyric acid type A receptor function inhibitors, and recorded latencies to myoclonic and generalized tonic-clonic seizures. RESULTS:Pcdh19 knockout and heterozygous females displayed increased seizure susceptibility across all current intensities in the 6-Hz psychomotor test, and increased severity overall. They also exhibited shorter latencies to generalized seizures following flurothyl, but not PTZ, seizure induction. Hemizygous males showed comparable seizure incidence and severity to their wild-type male littermates across all paradigms tested. SIGNIFICANCE: The heightened susceptibility observed in Pcdh19 knockout females suggests additional mechanisms other than cellular interference are at play in PCDH19-related epilepsy. Further experiments are needed to understand the variability in seizure susceptibility so that this model can be best utilized toward development of future therapeutic strategies for PCDH19-related epilepsy.
Authors: Daniel T Pederick; Kay L Richards; Sandra G Piltz; Raman Kumar; Stefka Mincheva-Tasheva; Simone A Mandelstam; Russell C Dale; Ingrid E Scheffer; Jozef Gecz; Steven Petrou; James N Hughes; Paul Q Thomas Journal: Neuron Date: 2018-01-03 Impact factor: 17.173
Authors: C Marini; D Mei; L Parmeggiani; V Norci; E Calado; A Ferrari; A Moreira; T Pisano; N Specchio; F Vigevano; D Battaglia; R Guerrini Journal: Neurology Date: 2010-08-17 Impact factor: 9.910
Authors: Ingrid E Scheffer; Samantha J Turner; Leanne M Dibbens; Marta A Bayly; Kathryn Friend; Bree Hodgson; Linda Burrows; Marie Shaw; Chen Wei; Reinhard Ullmann; Hans-Hilger Ropers; Pierre Szepetowski; Eric Haan; Aziz Mazarib; Zaid Afawi; Miriam Y Neufeld; P Ian Andrews; Geoffrey Wallace; Sara Kivity; Dorit Lev; Tally Lerman-Sagie; Christopher P Derry; Amos D Korczyn; Jozef Gecz; John C Mulley; Samuel F Berkovic Journal: Brain Date: 2008-01-29 Impact factor: 13.501
Authors: Melinda S Martin; Bin Tang; Ligia A Papale; Frank H Yu; William A Catterall; Andrew Escayg Journal: Hum Mol Genet Date: 2007-09-19 Impact factor: 6.150
Authors: Leanne M Dibbens; Patrick S Tarpey; Kim Hynes; Marta A Bayly; Ingrid E Scheffer; Raffaella Smith; Jamee Bomar; Edwina Sutton; Lucianne Vandeleur; Cheryl Shoubridge; Sarah Edkins; Samantha J Turner; Claire Stevens; Sarah O'Meara; Calli Tofts; Syd Barthorpe; Gemma Buck; Jennifer Cole; Kelly Halliday; David Jones; Rebecca Lee; Mark Madison; Tatiana Mironenko; Jennifer Varian; Sofie West; Sara Widaa; Paul Wray; John Teague; Ed Dicks; Adam Butler; Andrew Menzies; Andrew Jenkinson; Rebecca Shepherd; James F Gusella; Zaid Afawi; Aziz Mazarib; Miriam Y Neufeld; Sara Kivity; Dorit Lev; Tally Lerman-Sagie; Amos D Korczyn; Christopher P Derry; Grant R Sutherland; Kathryn Friend; Marie Shaw; Mark Corbett; Hyung-Goo Kim; Daniel H Geschwind; Paul Thomas; Eric Haan; Stephen Ryan; Shane McKee; Samuel F Berkovic; P Andrew Futreal; Michael R Stratton; John C Mulley; Jozef Gécz Journal: Nat Genet Date: 2008-05-11 Impact factor: 38.330
Authors: I M de Lange; P Rump; R F Neuteboom; P B Augustijn; K Hodges; A I Kistemaker; O F Brouwer; G M S Mancini; H A Newman; Y J Vos; K L Helbig; C Peeters-Scholte; M Kriek; N V Knoers; D Lindhout; B P C Koeleman; M J A van Kempen; E H Brilstra Journal: Neurogenetics Date: 2017-07-01 Impact factor: 2.660
Authors: Baoyu Chen; Klaus Brinkmann; Zhucheng Chen; Chi W Pak; Yuxing Liao; Shuoyong Shi; Lisa Henry; Nick V Grishin; Sven Bogdan; Michael K Rosen Journal: Cell Date: 2014-01-16 Impact factor: 41.582
Authors: Andrzej W Cwetsch; Ilias Ziogas; Roberto Narducci; Annalisa Savardi; Maria Bolla; Bruno Pinto; Laura E Perlini; Silvia Bassani; Maria Passafaro; Laura Cancedda Journal: Brain Commun Date: 2022-04-05
Authors: Barbara K Robens; Xinzhu Yang; Christopher M McGraw; Laura H Turner; Carsten Robens; Summer Thyme; Alexander Rotenberg; Annapurna Poduri Journal: Neurobiol Dis Date: 2022-04-20 Impact factor: 7.046